Efficacy and safety of the use of SGLT2 inhibitors in patients on incremental hemodialysis: maximizing residual renal function, is there a role for SGLT2 inhibitors?
Keywords:
Diabetic kidney disease
Incremental hemodialysis
Kidney replacement therapy
End stage renal disease
Residual kidney
function
Sodium/glucose cotransporter-2 inhibitor
Note:
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Citation:
de la Flor, J. C.; Villa-Hurtado, D. (Daniel); Cruzado, L.; et al. "Efficacy and safety of the use of SGLT2 inhibitors in patients on incremental hemodialysis: maximizing residual renal function, is there a role for SGLT2 inhibitors?". Biomedicines. 11 (7), 2023, 1908
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.